HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Feline Sarcoma Virus

Feline Sarcoma Virus

Feline Sarcoma Virus (FeSV) is a retrovirus notorious for instigating sarcomas in cats, serving as a pivotal tool in cancer research. FeSV's knack for integrating its genetic material into the host's genome unleashes unchecked cell proliferation, culminating in tumor genesis. Investigation into FeSV has yielded profound insights into oncogenesis, tumor immunology, and therapeutic modalities. It serves as a potent model for unraveling the complexities of cancer biology, encompassing tumor initiation, progression, and metastasis. The exploration of FeSV's intricacies has catalyzed the innovation of groundbreaking cancer treatments and preventive vaccines, benefiting both feline and human cohorts. By deciphering the nuances of FeSV-induced oncogenesis, researchers strive to unveil overarching principles pivotal in combatting cancer across species domains.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp